Kymab appoints Dr David Chiswell as Chief Executive Officer

Kymab, the Cambridge-based antibodies-to-medicines company, announced today the appointment of Dr David Chiswell OBE as Chief Executive Officer (“CEO”) with effect from April 2016.  Dr Chiswell has occupied the position as Kymab interim CEO since early 2015 having been appointed Chairman in September 2013. Dr Chiswell will step down from his role as Chairman and Dr Tim Rink will take the role of Lead Director with effect from April.